sanofi pasteur
 
Menactra® - Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diptheria Toxoid Conjugate Vaccine
Canadian visitors please visit
menactra.ca
 

Health-Care Professional In-Office Resources

Product Image

The meningococcal vaccination Call-Back System will help you and your staff keep track of the adolescents in your practice who need to be vaccinated in order to reduce the risk of meningococcal disease.

Patient Call-Back Image
Click on image to order

Click here to view and download Menactra Vaccine Prescribing Information.

The Meningococcal Disease Case Response Program is a value-added service that offers resources you can use in the event of a case in the community.

A case of meningococcal disease reported in the community can cause parents to worry that their children are at risk for this serious, yet potentially vaccine-preventable, disease.

The Meningococcal Disease Case Response Program was developed to:

  • Help you and your staff prepare for an influx of parent calls when a local case occurs
  • Offer tools to educate your patients and their parents about meningococcal disease, diagnosis, treatment, immunization, and other public health recommendations

The following resource material is now available for viewing and downloading:

Vaccine Information Sheet